Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1945 6
1946 41
1947 24
1948 31
1949 21
1950 20
1951 21
1952 29
1953 29
1954 44
1955 44
1956 26
1957 28
1958 34
1959 31
1960 33
1961 40
1962 51
1963 88
1964 166
1965 178
1966 239
1967 356
1968 445
1969 512
1970 593
1971 687
1972 639
1973 866
1974 979
1975 1498
1976 1569
1977 1564
1978 1731
1979 1897
1980 2147
1981 2219
1982 2569
1983 3043
1984 3465
1985 3935
1986 4086
1987 4563
1988 5303
1989 6144
1990 6711
1991 7109
1992 7790
1993 8579
1994 9128
1995 9688
1996 10134
1997 10394
1998 11209
1999 11077
2000 11854
2001 12526
2002 13136
2003 14955
2004 16090
2005 18261
2006 19427
2007 21367
2008 23186
2009 24298
2010 26259
2011 29661
2012 31649
2013 33426
2014 35520
2015 36734
2016 36817
2017 36867
2018 37707
2019 40030
2020 42819
2021 42888
2022 40878
2023 36609
2024 14918

Text availability

Article attribute

Article type

Publication date

Search Results

745,260 results

Results by year

Filters applied: . Clear all
Quoted phrase not found in phrase index: "Disorder of the genitourinary system"
Page 1
Practical Treatment Considerations in the Management of Genitourinary Syndrome of Menopause.
Kagan R, Kellogg-Spadt S, Parish SJ. Kagan R, et al. Drugs Aging. 2019 Oct;36(10):897-908. doi: 10.1007/s40266-019-00700-w. Drugs Aging. 2019. PMID: 31452067 Free PMC article. Review.
Genitourinary syndrome of menopause is a condition comprising the atrophic symptoms and signs women may experience in the vulvovaginal and bladder-urethral areas as a result of the loss of sex steroids that occurs with menopause. ...Additionally, many healthcare providers …
Genitourinary syndrome of menopause is a condition comprising the atrophic symptoms and signs women may experience in the vulvovagina …
The Burden of Candidate Pathogenic Variants for Kidney and Genitourinary Disorders Emerging From Exome Sequencing.
Rasouly HM, Groopman EE, Heyman-Kantor R, Fasel DA, Mitrotti A, Westland R, Bier L, Weng C, Ren Z, Copeland B, Krithivasan P, Chung WK, Sanna-Cherchi S, Goldstein DB, Gharavi AG. Rasouly HM, et al. Ann Intern Med. 2019 Jan 1;170(1):11-21. doi: 10.7326/M18-1241. Epub 2018 Nov 27. Ann Intern Med. 2019. PMID: 30476936
OBJECTIVE: To examine the burden of candidate pathogenic variants for kidney and genitourinary disorders emerging from exome sequencing. DESIGN: Secondary analysis of genetic data. ...PRIMARY FUNDING SOURCE: National Institute of Diabetes and Digestive and Kidney Diseas …
OBJECTIVE: To examine the burden of candidate pathogenic variants for kidney and genitourinary disorders emerging from exome sequenci …
Safety of Vaginal Estrogen Therapy for Genitourinary Syndrome of Menopause in Women With a History of Breast Cancer.
Agrawal P, Singh SM, Able C, Dumas K, Kohn J, Kohn TP, Clifton M. Agrawal P, et al. Obstet Gynecol. 2023 Sep 1;142(3):660-668. doi: 10.1097/AOG.0000000000005294. Epub 2023 Aug 3. Obstet Gynecol. 2023. PMID: 37535961
Our cohort consisted of women diagnosed with breast cancer within 5 years before the initial genitourinary syndrome of menopause diagnosis. Patients with active disease , defined as those undergoing mastectomy, radiation treatment, or chemotherapy within 3 months before di …
Our cohort consisted of women diagnosed with breast cancer within 5 years before the initial genitourinary syndrome of menopause diag …
An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction.
Haylen BT, de Ridder D, Freeman RM, Swift SE, Berghmans B, Lee J, Monga A, Petri E, Rizk DE, Sand PK, Schaer GN; International Urogynecological Association; International Continence Society. Haylen BT, et al. Neurourol Urodyn. 2010;29(1):4-20. doi: 10.1002/nau.20798. Neurourol Urodyn. 2010. PMID: 19941278 Review.
Hematuria.
Sokolosky MC. Sokolosky MC. Emerg Med Clin North Am. 2001 Aug;19(3):621-32. doi: 10.1016/s0733-8627(05)70206-6. Emerg Med Clin North Am. 2001. PMID: 11554278 Review.
The dynias.
Wesselmann U, Reich SG. Wesselmann U, et al. Semin Neurol. 1996 Mar;16(1):63-74. doi: 10.1055/s-2008-1040961. Semin Neurol. 1996. PMID: 8879059 Review.
The "dynias" are a group of chronic, focal pain syndromes with a predilection for the orocervical and urogenital regions. They include glossodynia, carotidynia, vulvodynia, orchidynia, prostatodynia, coccygodynia, and proctodynia. ...
The "dynias" are a group of chronic, focal pain syndromes with a predilection for the orocervical and urogenital regions. They includ …
Artificial sphincter.
Amend B, Toomey P, Sievert KD. Amend B, et al. Curr Opin Urol. 2013 Nov;23(6):520-7. doi: 10.1097/01.MOU.0000434591.02823.d0. Curr Opin Urol. 2013. PMID: 24080811 Review.
Mycoplasma genitalium Infection in Men.
Horner PJ, Martin DH. Horner PJ, et al. J Infect Dis. 2017 Jul 15;216(suppl_2):S396-S405. doi: 10.1093/infdis/jix145. J Infect Dis. 2017. PMID: 28838074 Free PMC article. Review.
The promise of regenerative medicine in the treatment of urogenital disorders.
Keshel SH, Rahimi A, Hancox Z, Ebrahimi M, Khojasteh A, Sefat F. Keshel SH, et al. J Biomed Mater Res A. 2020 Aug 1;108(8):1747-1759. doi: 10.1002/jbm.a.36942. Epub 2020 May 6. J Biomed Mater Res A. 2020. PMID: 32270582 Review.
Polymers and scaffolds are the most significant tools in regenerative medicine. Urogenital disorders are an important group of diseases that greatly affect the patient's life expectancy and quality. Reconstruction of urogenital defects is one of the current c …
Polymers and scaffolds are the most significant tools in regenerative medicine. Urogenital disorders are an important group of dis …
Genitourinary syndrome of menopause.
Farrell Am E. Farrell Am E. Aust Fam Physician. 2017;46(7):481-484. Aust Fam Physician. 2017. PMID: 28697291 Free article.
BACKGROUND: Genitourinary syndrome of menopause (GSM) is the new term for vulvovaginal atrophy (VVA). Oestrogen deficiency symptoms in the genitourinary tract are bothersome in more than 50% of women, having an adverse impact on quality of life, social activity and …
BACKGROUND: Genitourinary syndrome of menopause (GSM) is the new term for vulvovaginal atrophy (VVA). Oestrogen deficiency symptoms i …
745,260 results
You have reached the last available page of results. Please see the User Guide for more information.